NutriBand Inc. (NTRB) stock
NTRBNasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends January 31
Financials through Q2 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 4, 2026Score 4/30239% above fair value
$5.59−0.22 (-3.79%)
Close on Nov 17, 2026Market cap $67.95MP/E –Yield –
NutriBand operating margin
Operating margin is operating income as a percentage of revenue.
NutriBand's operating margin for the twelve months ending Jul 31, 2026 was -435.6%. For fiscal 2026 it was -408.4%, against -480.7% the year before. The highest annual figure on record is -215.2% in fiscal 2023.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2026 | Jan 31, 2026 | -408.4% | +72.3 |
| FY2025 | Jan 31, 2025 | -480.7% | −247.1 |
| FY2024 | Jan 31, 2024 | -233.6% | −18.4 |
| FY2023 | Jan 31, 2023 | -215.2% | +214.5 |
| FY2022 | Jan 31, 2022 | -429.7% | −154.6 |
| FY2021 | Jan 31, 2021 | -275.1% | +1374.9 |
| FY2020 | Jan 31, 2020 | -1649.9% | −291.8 |
| FY2019 | Jan 31, 2019 | -1358.1% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2027CQ2 2026 | Jul 31, 2026 | -203.6% | +118.3 |
| Q1 FY2027CQ1 2026 | Apr 30, 2026 | -289.4% | −77.6 |
| Q4 FY2026CQ4 2025 | Jan 31, 2026 | -254.8% | +610.6 |
| Q3 FY2026CQ3 2025 | Oct 31, 2025 | -1121.3% | −900.4 |
| Q2 FY2026CQ2 2025 | Jul 31, 2025 | -321.8% | −3.5 |
| Q1 FY2026CQ1 2025 | Apr 30, 2025 | -211.8% | +250.7 |
| Q4 FY2025CQ4 2024 | Jan 31, 2025 | -865.3% | −616.3 |
| Q3 FY2025CQ3 2024 | Oct 31, 2024 | -220.9% | +181.9 |
| Q2 FY2025CQ2 2024 | Jul 31, 2024 | -318.3% | −192.7 |
| Q1 FY2025CQ1 2024 | Apr 30, 2024 | -462.5% | −249.1 |
| Q4 FY2024CQ4 2023 | Jan 31, 2024 | -249.0% | +70.1 |
| Q3 FY2024CQ3 2023 | Oct 31, 2023 | -402.8% | −229.5 |
| Q2 FY2024CQ2 2023 | Jul 31, 2023 | -125.7% | +101.1 |
| Q1 FY2024CQ1 2023 | Apr 30, 2023 | -213.4% | −69.9 |
| Q4 FY2023CQ4 2022 | Jan 31, 2023 | -319.1% | +448.3 |
| Q3 FY2023CQ3 2022 | Oct 31, 2022 | -173.4% | −100.9 |
| Q2 FY2023CQ2 2022 | Jul 31, 2022 | -226.7% | +400.0 |
| Q1 FY2023CQ1 2022 | Apr 30, 2022 | -143.5% | −133.1 |
| Q4 FY2022CQ4 2021 | Jan 31, 2022 | -767.5% | −500.1 |
| Q1 FY2022CQ1 2021 | Apr 30, 2021 | -72.5% | +51.1 |
| Q4 FY2021CQ4 2020 | Jan 31, 2021 | -626.8% | +2520.3 |
| Q3 FY2021CQ3 2020 | Oct 31, 2020 | -10.5% | +389.9 |
| Q2 FY2021CQ2 2020 | Jul 31, 2020 | -267.4% | +332.8 |
| Q1 FY2021CQ1 2020 | Apr 30, 2020 | -123.6% | +172.5 |
| Q4 FY2020CQ4 2019 | Jan 31, 2020 | -3147.0% | −2521.6 |
| Q3 FY2020CQ3 2019 | Oct 31, 2019 | -400.4% | −100.3 |
| Q2 FY2020CQ2 2019 | Jul 31, 2019 | -600.2% | – |
| Q1 FY2020CQ1 2019 | Apr 30, 2019 | -296.1% | – |
| Q4 FY2019CQ4 2018 | Jan 31, 2019 | -625.4% | – |
| Q3 FY2019CQ3 2018 | Oct 31, 2018 | -300.1% | – |
See a number that looks wrong?